Researchers have developed a machine learning algorithm, called NRPminer, that makes it easier for scientists to develop drugs from natural […]
American biotech, Insilico Medicine and research tech company, Arctoris Ltd, have announced a technology partnership to jointly discover and profile […]
Differences in genetics, physiology, race, ethnicity, age, and sex, as well as numerous other extrinsic factors, are known to affect […]
The chemistry services team at EMBL has announced that they will provide an informatics infrastructure to the IMI-funded EUbOPEN Consortium […]
Ample Market Research has last month published their analysis of the Artificial intelligence market for drug development, to highlight the […]
Artificial intelligence, unsurprisingly, has been the leading technology pitched to solve most of our newfound pandemic problems, from finding a […]
Since nearly as long as we’ve enjoyed the company of SARS-Cov-2, we’ve heard the cynics and sceptics among us forecast […]
We value and respect you as a visitor to our website, and consumer of our services. In turn, we take […]
Dr Halima Moncrieffe is an Assistant Professor at Cincinnati Children’s Hospital, ranked top 3 in the USA, where she combines genomics with immunology to understand medication response and disease etiology. Halima is an award-winning immunologist who’s ultimate goal is to move towards a cure for Juvenile Idiopathic Arthritis, so children can live pain-free and to their full potential
FLG: Could you introduce yourself and tell us about the work you are currently doing at Roche? I am a […]
